- Home
- JUNS vs OSUR Comparison
JUNS vs OSUR Comparison
Compare JUNS & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JUNS
- OSUR
- Stock Information
- Founded
- JUNS 2015
- OSUR 2000
- Country
- JUNS United States
- OSUR United States
- Employees
- JUNS N/A
- OSUR N/A
- Industry
- JUNS
- OSUR Medical/Dental Instruments
- Sector
- JUNS
- OSUR Health Care
- Exchange
- JUNS NYSE
- OSUR Nasdaq
- Market Cap
- JUNS 281.4M
- OSUR 266.7M
- IPO Year
- JUNS 2024
- OSUR 1986
- Fundamental
- Price
- JUNS $0.76
- OSUR $3.44
- Analyst Decision
- JUNS
- OSUR Hold
- Analyst Count
- JUNS 0
- OSUR 2
- Target Price
- JUNS N/A
- OSUR $5.50
- AVG Volume (30 Days)
- JUNS 121.4K
- OSUR 1.0M
- Earning Date
- JUNS 05-11-2025
- OSUR 05-07-2025
- Dividend Yield
- JUNS N/A
- OSUR N/A
- EPS Growth
- JUNS N/A
- OSUR N/A
- EPS
- JUNS N/A
- OSUR N/A
- Revenue
- JUNS N/A
- OSUR $185,827,000.00
- Revenue This Year
- JUNS N/A
- OSUR N/A
- Revenue Next Year
- JUNS N/A
- OSUR $8.41
- P/E Ratio
- JUNS N/A
- OSUR N/A
- Revenue Growth
- JUNS N/A
- OSUR N/A
- 52 Week Low
- JUNS $0.55
- OSUR $2.69
- 52 Week High
- JUNS $19.51
- OSUR $6.69
- Technical
- Relative Strength Index (RSI)
- JUNS N/A
- OSUR 45.82
- Support Level
- JUNS N/A
- OSUR $3.40
- Resistance Level
- JUNS N/A
- OSUR $3.55
- Average True Range (ATR)
- JUNS 0.00
- OSUR 0.15
- MACD
- JUNS 0.00
- OSUR 0.02
- Stochastic Oscillator
- JUNS 0.00
- OSUR 56.52
About JUNS JUPITER NEUROSCIENCES INC
Jupiter Neurosciences Inc is a clinical stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a unique resveratrol platform product primarily targeting treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to most central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.